AGIO
Agios PharmNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.75B
P/E Ratio
—
EPS
$-7.26
Beta
0.59
52W High
$46.00
52W Low
$22.24
50-Day MA
$29.19
200-Day MA
$31.85
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.47
PEG Ratio
0.00
About Agios Pharm
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $66.05M |
| Gross Profit (TTM) | $-288.47M |
| EBITDA | $-470.27M |
| Operating Margin | -530.00% |
| Return on Equity | -32.80% |
| Return on Assets | -21.70% |
| Revenue/Share (TTM) | $1.13 |
| Book Value | $18.69 |
| Price-to-Book | 0.72 |
| Price-to-Sales (TTM) | 26.53 |
| EV/Revenue | 25.06 |
| EV/EBITDA | -2.33 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 137.70% |
| Shares Outstanding | $59.47M |
| Float | $53.13M |
| % Insiders | 1.09% |
| % Institutions | 108.61% |
Historical Volatility
HV 10-Day
57.98%
HV 20-Day
50.29%
HV 30-Day
42.38%
HV 60-Day
75.46%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($40.25 target)
7
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026